Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

Vancomycin (VAN) and daptomycin (DAP) are approved as a monotherapy for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. A regimen of daptomycin plus ceftaroline (DAP+CPT) has shown promise in published case series of MRSA salvage therapy, but no comparative data exist to compare up-fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Geriak, Matthew, Haddad, Fadi, Rizvi, Khulood, Rose, Warren, Kullar, Ravina, LaPlante, Kerry, Yu, Marie, Vasina, Logan, Ouellette, Krista, Zervos, Marcus, Nizet, Victor, Sakoulas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6496065/
https://www.ncbi.nlm.nih.gov/pubmed/30858203
http://dx.doi.org/10.1128/AAC.02483-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6496065/
https://www.ncbi.nlm.nih.gov/pubmed/30858203
http://dx.doi.org/10.1128/AAC.02483-18

Ejemplares similares